PROTHENA CORP PUBLIC LTD CO
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $9.7 | $135.2 | $91.4 | $53.9 | $200.6 |
| Operating income | -$214.6 | -$154.6 | -$191.0 | -$131.6 | $72.0 |
| Net income | -$244.1 | -$122.3 | -$147.0 | -$116.9 | $67.0 |
Shares outstanding 51.3M · Free float 55.3%
Annual filing data through FY ended December 31, 2025; float as of September 30, 2026.
Coverage
October 11, 2026
Insider Signal
Microcap Insider Buying: Week Ending October 9, 2026
October 5, 2026
Insider Signal
Microcap Insider Buying: Week Ending October 2, 2026
September 28, 2026
QBook
Stronger demand supports expansion as pricing diverges
August 14, 2026
Industry Earnings Roundup
Healthcare Earnings: Demand Surges, Costs Bite Back